NCT00775996 is a NA clinical trial of Clorazepate Dipotassium 15mg Tablets in Healthy, sponsored by Ranbaxy Laboratories Limited.

Who is sponsoring NCT00775996?

NCT00775996 is sponsored by Ranbaxy Laboratories Limited.

What drugs are being tested in NCT00775996?

Interventions in NCT00775996: Clorazepate Dipotassium 15mg Tablets.

Is NCT00775996 still recruiting?

NCT00775996 is currently completed. Last updated 17 October 2008.

Last reviewed 2008-10-17 · How we verify

NCT00775996

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Objective of This Study Was to Compare the Single-Dose Relative Bioavailability of Ranbaxy and Abbott (Tranxene® T-Tab®) 15 mg Clorazepate Dipotassium Tablets Under Fasting Conditions.

Completed NA Last updated 17 October 2008

What this trial tests

NA trial testing Clorazepate Dipotassium 15mg Tablets in Healthy in 32 participants. Completed in 1 November 2003.

Timeline

1 August 2003

Primary endpoint
1 September 2003

1 November 2003

Quick facts

Lead sponsor	Ranbaxy Laboratories Limited
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Enrollment	32
Start date	1 August 2003
Primary completion	1 September 2003
Estimated completion	1 November 2003
Sites	1 location across United States

Drugs / interventions tested

Clorazepate Dipotassium 15mg Tablets — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Ranbaxy Laboratories Limited — full company profile →

Who can join

Adults 18 to 55, any sex, with Healthy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Bioequivalence

Sponsor's own description

The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Abbott (TranxeneeT-Tab®) 15 mg clorazepate dipotassium tablets under fasting conditions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00775996 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ranbaxy Laboratories Limited
Last refreshed: 17 October 2008

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00775996.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing